When MRI offered no clear answer in suspected prostate cancer, the use of prostate-specific membrane antigen (PSMA)-PET/CT showed promise for reducing the number of biopsies without compromising the ...

AI-assisted imaging improved prostate cancer diagnosis and biopsy decision-making in new research presented at EAU 2026.

An imaging test could safely halve the number of people who need a biopsy for suspected prostate cancer following ...

At ECR 2026, under the theme "Rays of Knowledge", United Imaging Intelligence (UII) showcased a comprehensive suite of pioneering AI ...

Molecular profiling of tumors has been shown to improve risk stratification, and it may be useful for prostate cancer active surveillance.

DeepHealth is introducing in Europe its cloud-first integrated portfolio combining clinical AI, multi-modality viewing and reporting, which is designed to improve outcomes, efficiency and access to ca ...

Sequential flotufolastat-F18 PSMA-PET scans to enhance detection of prostate cancer in patients with early PSA recurrence following radical prostatectomy. Prevalence of treatment-acquired homozygous ...

HERCULES, Calif. (AP) — HERCULES, Calif. (AP) — Bio-Rad Laboratories Inc. (BIO) on Thursday reported fourth-quarter net income of $720 million, after reporting a loss in the same period a year earlier ...

Alam frames PHI and MRI as noninvasive tools that help refine risk before proceeding to biopsy. In this video, Ridwan I. Alam, MD, MPH, discusses how the Prostate Health Index (PHI) performs alongside ...

Pi Network price has crashed to a record low this year. The crash happened and erased nearly $18 billion in value. The article explores some reasons why it crashed and what to expect. Pi Network, a ...